| AAEP | American Association of Equine Practitioners |
| ACD/ACD-A | Acid Citrate Dextrose A |
| ACTH | Adrenocorticotropic Hormone |
| ALL | Allogeneic |
| APS | Autologous Protein Solution |
| AUT | Autologous |
| CaCl2 | Calcium Chloride |
| CES(s) | Controlled Experimental Studies |
| CL-PRP | Calcium-activated Leukocyte-rich Platelet-Rich Plasma |
| CS(s) | Case Series |
| GFs | Growth Factors |
| HA | Hyaluronic Acid |
| IAI | Intra-Articular Injection |
| IFN-γ | Interferon gamma |
| IL-1β | Interleukin 1 beta |
| IL-6 | Interleukin 6 |
| IL-10 | Interleukin 10 |
| IL-17A | Interleukin 17A |
| L-PRP | Leukocyte-rich Platelet-Rich Plasma |
| NSAIDs | Non-Steroidal Anti-Inflammatory Drugs |
| OA | Osteoarthritis |
| OST | Oral Sugar Test |
| P-PRP | Pure Platelet-Rich Plasma |
| PDGF-BB | Platelet-Derived Growth Factor-BB |
| PGE2 | Prostaglandin E2 |
| PICO | Population, Intervention, Comparison, Outcome |
| PLT | Platelet |
| PRG | Platelet-Rich Gel |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| PRP | Platelet-Rich Plasma |
| RBC | Red Blood Cells |
| RCT(s) | Randomized Clinical Trial(s) |
| Robvis | Risk-of-bias VISualization |
| ROBINS-I | Risk Of Bias In Non-randomized Studies of Interventions |
| RoB 2.0 | Revised Cochrane risk-of-bias tool for randomized trials |
| SAA | Serum Amyloid A |
| SA | Septic Arthritis |
| SC | Sodium Citrate |
| WOS | Web of Science |
| STNFr1 | Soluble Tumor Necrosis Factor Receptor 1 |
| TA | Triamcinolone Acetonide |
| TGF-β1 | Transforming Growth Factor beta 1 |
| TNF-α | Tumor Necrosis Factor alpha |
| TRH | Thyrotropin-Releasing Hormone |
| WBC | White Blood Cells |